查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1981183

2026年全球医疗保健领域生成式人工智慧市场报告

Generative AI In Medicine Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医疗领域生成式人工智慧的市场规模呈现爆炸性成长。预计该市场规模将从2025年的9.5亿美元成长到2026年的13.6亿美元，复合年增长率高达43.7%。过去几年的成长主要归功于医学影像技术的进步、医院和诊所对人工智慧的日益普及、临床研究投入的增加、对个人化医疗需求的增长以及用于增强电子健康记录（EHR）的工具的开发。

预计未来几年，医疗保健领域生成式人工智慧的市场规模将大幅成长。到2030年，该市场规模预计将达到57.7亿美元，复合年增长率（CAGR）高达43.4%。预测期内的成长预计将受到以下因素的推动：人工智慧驱动的药物研发解决方案的扩展、生成式人工智慧在治疗方案製定中的应用、虚拟护理助理的日益普及、机器人辅助人工智慧手术的采用以及患者数据预测分析的扩展。预测期内的关键趋势包括：人工智慧驱动的诊断工具、个人化治疗方案製定、虚拟护理助理、机器人辅助人工智慧手术、病患资料分析和预测医学。

数位健康记录的激增预计将推动医疗保健领域生成式人工智慧市场的成长。数位健康记录，也称为电子健康记录 (EHR)，是对电子储存的患者健康资讯的系统性收集，它能够实现跨医疗保健环境的数据共用，并提高医疗服务的品质和效率。数位健康记录的成长得益于患者照护的改善、医疗服务效率的提高、监管支援、技术进步以及病人参与的增强。医疗保健领域的人工智慧 (AI) 透过自动建立文件、建立临床数据结构、生成预测性见解以及创建个人化摘要来增强数位健康记录，从而提高准确性、可访问性和患者疗效。例如，根据欧盟执行机构欧盟委员会的数据，截至 2024 年 7 月，电子健康记录的存取率已从 2023 年的 72% 增长到 2024 年的 79%。因此，电子健康记录的普及正在促进医疗保健领域生成式人工智慧 (AI) 市场的成长。

在医疗领域，主要企业正致力于开发创新技术，例如用于大脑健康和福祉的AI解决方案，以推进认知功能评估、改善患者照护并加强心理健康管理。用于大脑健康和福祉的AI解决方案是旨在评估、监测和支持认知功能和心理健康的先进技术。例如，总部位于加拿大的DiagnaMed Holdings Corp.于2024年2月发布了CERVAI，这是一款专门针对人类心理健康和福祉的AI解决方案。 CERVAI利用先进的演算法分析认知功能测试、脑部影像和其他输入数据，提供个人化评估和可操作的建议，从而支持对认知问题的早期发现和针对性干预。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球医疗保健领域生成式人工智慧市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 身临其境型技术（AR/VR/XR）与数位体验
  • 主要趋势
    • 人工智慧驱动的诊断工具
    • 个人化治疗方案
    • 虚拟护理助理
    • 机器人辅助人工智慧手术
    • 患者数据分析和预测医学

第五章 终端用户产业市场分析

  • 医院和诊所
  • 临床研究机构
  • 医疗机构
  • 诊断中心
  • 製药公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球医疗保健领域生成式人工智慧市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球医疗保健生成式人工智慧市场规模、对比及成长率分析
  • 全球医疗保健生成式人工智慧市场表现：规模与成长，2020-2025年
  • 全球医疗保健领域生成式人工智慧市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按组件
  • 解决方案、服务
  • 按功能
  • 虚拟护理助理、机器人辅助人工智慧手术、管理流程优化、医学影像分析
  • 透过使用
  • 医学影像、药物研发、医学诊断、病患资料分析及其他应用
  • 最终用户
  • 医院和诊所、临床研究机构、医疗设施、诊断中心和其他最终用户
  • 按类型细分：解决方案
  • 诊断工具、治疗计划系统、个人化医疗平台、药物发现和开发解决方案、医学影像和分析软体以及电子健康记录 (EHR) 增强工具。
  • 按类型细分：服务
  • 咨询服务、实施和整合服务、培训和教育服务、技术支援和维护、研发服务

第十章 市场与产业指标：依国家划分

第十一章 区域与国别分析

  • 全球医疗保健领域生成式人工智慧市场：按地区划分，实际结果和预测，2020-2025年、2025-2030年、2035年
  • 全球医疗保健领域生成式人工智慧市场：按国家/地区划分，实际结果和预测，2020-2025 年、2025-2030 年、2035 年

第十二章 亚太市场

第十三章：中国市场

第十四章：印度市场

第十五章：日本市场

第十六章：澳洲市场

第十七章：印尼市场

第十八章：韩国市场

第十九章 台湾市场

第二十章：东南亚市场

第21章 西欧市场

第22章英国市场

第23章：德国市场

第24章：法国市场

第25章：义大利市场

第26章：西班牙市场

第27章 东欧市场

第28章：俄罗斯市场

第29章 北美市场

第三十章：美国市场

第31章：加拿大市场

第32章：南美洲市场

第33章：巴西市场

第34章 中东市场

第35章：非洲市场

第三十六章 市场监理与投资环境

第37章：竞争格局与公司概况

  • 医疗保健领域生成式人工智慧市场：竞争格局与市场占有率（2024 年）
  • 医疗保健领域生成式人工智慧市场：公司估值矩阵
  • 医疗保健领域的生成式人工智慧市场：公司概况
    • Microsoft Corporation
    • Intel Corporation
    • International Business Machines Corporation
    • NVIDIA Corporation
    • Philips Healthcare

第38章 其他大型企业和创新企业

  • Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI Inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI Inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd.

第39章 全球市场竞争基准分析与仪錶板

第四十章 重大併购

第41章 具有高市场潜力的国家、细分市场与策略

  • 2030年医疗保健领域生成式人工智慧市场：提供新机会的国家
  • 2030年医疗保健领域生成式人工智慧市场：新兴细分市场机会
  • 2030年医疗保健领域生成式人工智慧市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第42章附录

简介目录
Product Code: IT5MGAMI06_G26Q1

Generative artificial intelligence (AI) in medicine involves using AI systems to create new data, models, or insights to advance healthcare and medical research. Its goal is to enhance diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.

Key components of generative AI in medicine include solutions and services. In this context, solutions refer to the advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions cover a broad range of applications, such as AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. Key functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. Applications span medical imaging, drug discovery, medical diagnosis, patient data analysis, and more. These technologies are utilized by various end-users, including hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

Tariffs have impacted the generative AI in medicine market by increasing the costs of imported AI software platforms, medical imaging devices, and robotic surgery equipment. Regions such as North America, Europe, and Asia-Pacific, which host major hospitals, research institutions, and diagnostic centers, are most affected. The tariffs can lead to higher implementation costs for advanced AI solutions in medical imaging, drug discovery, and robotic surgeries. However, tariffs are also encouraging local innovation in AI medical devices and software development, potentially accelerating regional adoption of generative AI in healthcare.

The generative AI in medicine market research report is one of a series of new reports from The Business Research Company that provides generative AI in medicine market statistics, including generative AI in medicine industry global market size, regional shares, competitors with a generative AI in medicine market share, detailed generative AI in medicine market segments, market trends and opportunities, and any further data you may need to thrive in the generative AI in medicine industry. This generative AI in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative AI in medicine market size has grown exponentially in recent years. It will grow from $0.95 billion in 2025 to $1.36 billion in 2026 at a compound annual growth rate (CAGR) of 43.7%. The growth in the historic period can be attributed to advancements in medical imaging technologies, increasing adoption of AI in hospitals and clinics, growth in clinical research initiatives, rising demand for personalized medicine, development of electronic health record (ehr) enhancement tools.

The generative AI in medicine market size is expected to see exponential growth in the next few years. It will grow to $5.77 billion in 2030 at a compound annual growth rate (CAGR) of 43.4%. The growth in the forecast period can be attributed to expansion of AI-assisted drug discovery solutions, integration of generative AI in treatment planning, increased use of virtual nursing assistants, adoption of robot-assisted AI surgery, growth in predictive patient data analytics. Major trends in the forecast period include AI-driven diagnostic tools, personalized treatment planning, virtual nursing assistants, robot-assisted AI surgery, patient data analysis and predictive healthcare.

The surge in digital health records is expected to support the growth of the generative artificial intelligence (AI) in medicine market going forward. Digital health records, also known as electronic health records (EHRs), are organized collections of patient health information stored electronically, enabling data sharing across healthcare environments and improving care quality and efficiency. The increase in digital health records is driven by improvements in patient care, greater efficiency in healthcare delivery, regulatory backing, technological advancements, and enhanced patient engagement. Artificial intelligence (AI) in medicine enhances digital health records by automating documentation, structuring clinical data, generating predictive insights, and creating personalized summaries to improve accuracy, accessibility, and patient outcomes. For example, in July 2024, according to the European Commission, a Belgium-based executive body of the European Union, access to electronic health records increased to 79% in 2024 from 72% in 2023. Therefore, the expansion of digital health records is contributing to the growth of the generative artificial intelligence (AI) in medicine market.

Leading companies operating in the generative artificial intelligence (AI) in medicine market are focused on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, enhance patient care, and improve mental health management. AI solutions for brain health and wellness are advanced technologies designed to assess, monitor, and support cognitive function and mental well-being. For example, in February 2024, DiagnaMed Holdings Corp., a Canada-based developer of AI-powered digital therapeutics, launched CERVAI, an AI solution dedicated to human mental health and wellness. CERVAI uses advanced algorithms to analyze cognitive tests, brain imaging, and other data inputs, providing personalized assessments and actionable recommendations that support early detection of cognitive issues and targeted interventions.

In December 2024, General Inception, a US-based biotech company igniter, acquired Enable Medicine for an undisclosed amount. Through this acquisition, General Inception aims to advance its generative AI and biological data capabilities by integrating Enable Medicine's platform, which applies generative AI to search disease-related cellular atlases and uncover novel therapeutic insights. Enable Medicine is a US-based software company specializing in AI-driven generative biological search for drug discovery.

Major companies operating in the generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI Inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI Inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative AI in medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative AI in medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Medicine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses generative AI in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative AI in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The generative AI in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Solutions; Service
  • 2) By Function: Virtual Nursing Assistants; Robot-Assisted AI Surgery; Administrative Process Optimization; Medical Imaging Analysis
  • 3) By Application: Medical Imaging; Drug Discovery; Medical Diagnosis; Patient Data Analysis; Other Applications
  • 4) By End-User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By Solutions: Diagnostic Tools; Treatment Planning Systems; Personalized Medicine Platforms; Drug Discovery And Development Solutions; Medical Imaging And Analysis Software; Electronic Health Record (EHR) Enhancement Tools
  • 2) By Services: Consulting Services; Implementation And Integration Services; Training And Education Services; Technical Support And Maintenance; Research And Development Services.
  • Companies Mentioned: Microsoft Corporation; Intel Corporation; International Business Machines Corporation; NVIDIA Corporation; Philips Healthcare; Veeva Systems Inc.; Nuance Communications Inc.; Babylon Health Ltd.; Tempus Labs Inc.; DeepMind Technologies Limited; Owkin Inc.; Viz.AI Inc.; Recursion Pharmaceuticals Inc.; Caresyntax Inc.; Relay Therapeutics Inc.; Exscientia plc; Paige AI Inc.; BenevolentAI Limited; Atomwise Inc.; Healx Ltd.; Zebra Medical Vision Ltd.; Eyenuk Inc.; Syntegra Ltd.; Arterys Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Generative AI In Medicine Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Generative AI In Medicine Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Generative AI In Medicine Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Generative AI In Medicine Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 AI-Driven Diagnostic Tools
    • 4.2.2 Personalized Treatment Planning
    • 4.2.3 Virtual Nursing Assistants
    • 4.2.4 Robot-Assisted AI Surgery
    • 4.2.5 Patient Data Analysis And Predictive Healthcare

5. Generative AI In Medicine Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Clinical Research Organizations
  • 5.3 Healthcare Organizations
  • 5.4 Diagnostic Centers
  • 5.5 Pharmaceutical Companies

6. Generative AI In Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Generative AI In Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Generative AI In Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Generative AI In Medicine Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Generative AI In Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Generative AI In Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Generative AI In Medicine Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Generative AI In Medicine Market Segmentation

  • 9.1. Global Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solutions, Service
  • 9.2. Global Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Virtual Nursing Assistants, Robot-Assisted AI Surgery, Administrative Process Optimization, Medical Imaging Analysis
  • 9.3. Global Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Medical Imaging, Drug Discovery, Medical Diagnosis, Patient Data Analysis, Other Applications
  • 9.4. Global Generative AI In Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers, Other End-Users
  • 9.5. Global Generative AI In Medicine Market, Sub-Segmentation Of Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Tools, Treatment Planning Systems, Personalized Medicine Platforms, Drug Discovery And Development Solutions, Medical Imaging And Analysis Software, Electronic Health Record (EHR) Enhancement Tools
  • 9.6. Global Generative AI In Medicine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Implementation And Integration Services, Training And Education Services, Technical Support And Maintenance, Research And Development Services

10. Generative AI In Medicine Market, Industry Metrics By Country

  • 10.1. Global Generative AI In Medicine Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global Generative AI In Medicine Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Generative AI In Medicine Market Regional And Country Analysis

  • 11.1. Global Generative AI In Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global Generative AI In Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Generative AI In Medicine Market

  • 12.1. Asia-Pacific Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Generative AI In Medicine Market

  • 13.1. China Generative AI In Medicine Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Generative AI In Medicine Market

  • 14.1. India Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Generative AI In Medicine Market

  • 15.1. Japan Generative AI In Medicine Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Generative AI In Medicine Market

  • 16.1. Australia Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Generative AI In Medicine Market

  • 17.1. Indonesia Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Generative AI In Medicine Market

  • 18.1. South Korea Generative AI In Medicine Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Generative AI In Medicine Market

  • 19.1. Taiwan Generative AI In Medicine Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Generative AI In Medicine Market

  • 20.1. South East Asia Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Generative AI In Medicine Market

  • 21.1. Western Europe Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Generative AI In Medicine Market

  • 22.1. UK Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Generative AI In Medicine Market

  • 23.1. Germany Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Generative AI In Medicine Market

  • 24.1. France Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Generative AI In Medicine Market

  • 25.1. Italy Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Generative AI In Medicine Market

  • 26.1. Spain Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Generative AI In Medicine Market

  • 27.1. Eastern Europe Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Generative AI In Medicine Market

  • 28.1. Russia Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Generative AI In Medicine Market

  • 29.1. North America Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Generative AI In Medicine Market

  • 30.1. USA Generative AI In Medicine Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Generative AI In Medicine Market

  • 31.1. Canada Generative AI In Medicine Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Generative AI In Medicine Market

  • 32.1. South America Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Generative AI In Medicine Market

  • 33.1. Brazil Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Generative AI In Medicine Market

  • 34.1. Middle East Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Generative AI In Medicine Market

  • 35.1. Africa Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa Generative AI In Medicine Market, Segmentation By Component, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Generative AI In Medicine Market Regulatory and Investment Landscape

37. Generative AI In Medicine Market Competitive Landscape And Company Profiles

  • 37.1. Generative AI In Medicine Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. Generative AI In Medicine Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. Generative AI In Medicine Market Company Profiles
    • 37.3.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.2. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.4. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.5. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

38. Generative AI In Medicine Market Other Major And Innovative Companies

  • Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI Inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI Inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd.

39. Global Generative AI In Medicine Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Generative AI In Medicine Market

41. Generative AI In Medicine Market High Potential Countries, Segments and Strategies

  • 41.1. Generative AI In Medicine Market In 2030 - Countries Offering Most New Opportunities
  • 41.2. Generative AI In Medicine Market In 2030 - Segments Offering Most New Opportunities
  • 41.3. Generative AI In Medicine Market In 2030 - Growth Strategies
    • 41.3.1. Market Trend Based Strategies
    • 41.3.2. Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer